“We’re studying how using HIPEC for T4 colon cancer reduces the possibility of future carcinomatosis. We’ve performed intermediate analysis and that analysis has been promising”

“We’re studying how using HIPEC for T4 colon cancer reduces the possibility of future carcinomatosis. We’ve performed intermediate analysis and that analysis has been promising”

by | Mar 25, 2022 | The Medical Innovators Interview

The Medical Innovators Interview #4 Dr Alvaro ArjonaFebruary 2022 Minimally invasive surgery vs open surgery, refining the laparoscopic approach for peritoneal carcinomatosis, AI and a key trial for HIPEC® in T4 colon cancer. Combat Medical’s Guy Cooper is discussing...